Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v4-FR
Language French French
Date Updated 2020-02-13 2020-02-13
Drug Identification Number 02305534 02305534
Brand name GEMCITABINE FOR INJECTION GEMCITABINE FOR INJECTION
Common or Proper name GEMCITABINE GEMCITABINE
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients GEMCITABINE GEMCITABINE
Strength(s) 1G 1G
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1000MG 1000MG
ATC code L01BC L01BC
ATC description ANTIMETABOLITES ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-11-01 2016-11-01
Estimated end date
Actual end date 2018-06-30 2018-06-30
Shortage status Resolved Resolved
Company comments Product Discontinued. Product Discontinued.
Health Canada comments